All Stories

  1. Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma

    Article • The FASEB Journal, June 2018, Federation of American Societies For Experimental Biology (FASEB)

    Professor Philip Lazarovici, Gadi Cohen